Mandate

Vinge advises Testing Machines Inc. on acquisition of Fibro System AB

January 20, 2012

Vinge advises Testing Machines Inc. (TMI) in connection with the acquisition of Fibro System AB. Fibro System develops, manufactures and sell measurement technology equipment for the pulp and paper, print, packaging and other related industries. TMI manufactures and markets physical property testing instruments for the paper, pulp, film, foil, ink, coatings, nonwoven, textile and corrugated industries. TMI has a network of sales offices and agents throughout the US and in over 50 countries.

The Vinge team advising TMI includes partner Malin Ohlin Åkermark and associates Peter Sundgren and Nina Farrahi (M&A), associate Albert Wållgren (banking & finance) and associate Karin Isacson (employment & benefits).

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025